Patented Medicine Prices Review Board
The Patented Medicine Prices Review Board (PMPRB) protects and informs Canadian consumers by reviewing the prices of patented medicines sold in Canada, and by reporting on pharmaceutical trends.
We are an independent quasi-judicial body that is part of the Health portfolio, and operate at arm’s-length from the Minister of Health.
We are in the process of moving our services and information to Canada.ca.
Our current Patented Medicine Prices Review Board website will remain available until the move to Canada.ca is complete.
Bouchard (Phoenix pay system) class action:
A settlement has been reached in the Bouchard class action against the Government of Canada. Consult the first notification to class members to learn more about the settlement, who’s included in the class action, how to participate in the hearing to approve the settlement, or how to opt out of the class action.
Latest news
Annual Report 2023
The PMPRB’s 2023 Annual Report was tabled by the Minister of Health on December 6, 2024.
Meds Pipeline Monitor 2023
The MPM lists new medicines in late stages of clinical evaluation that may impact clinical practice or drug spending.
Most requested
Contact us
More information for
Services and information
Regulatory Process
Find information on the PMPRB’s regulatory and investigative process.
Information for patentees
Find information on the PMPRB's statutory reporting requirements, guidance on filing requirements and deadlines, outreach presentations and recorded Webinar sessions, and answers to frequently-asked questions.
Reports and Trends
Find information on key trends in sales and prices of patented medicines, and in pharmaceutical industry investments in research and development.
Voluntary Compliance Undertakings
See what patented medicines have been the subject of a pricing investigation that was resolued through a mutually acceptable pricing agreement between the PMPRB and the patentee.
National Prescription Drug Utilization Information System
NPDUIS is a research initiative jointly conducted by the PMPRB and the Canadian Institute for Health Information (CIHI).
Get answers to your questions
Find quick and direct answers to frequently asked questions
Legislation
The Patented Medicine Prices Review Board operates within the boundaries of various legislation, regulations and guidelines.
Announcements and Information
Find the most recent announcements, notices, speeches, and other timely PMPRB information.
What we are doing
Corporate information
Management
Thomas J. Digby
Chairperson
Management
Guillaume Couillard
Director General
Features
Regulatory Process
The PMPRB is responsible for ensuring the prices that patentees charge for prescription and non-prescription patented medicines sold in Canada to wholesalers, hospitals, pharmacies or others, for human and veterinary use, are not excessive.
NPDUIS Analytical Studies
Every report and publication published by the NPDUIS group.
Consultations
Effective and meaningful stakeholder involvement is essential to enable the PMPRB to fulfil its mandate, deliver programs, launch new initiatives, and build public trust.
Page details
- Date modified: